Current and emerging management options for patients with Morquio A syndrome
about
Dose responsive effects of subcutaneous pentosan polysulfate injection in mucopolysaccharidosis type VI rats and comparison to oral treatmentEfficacy and safety of enzyme replacement therapy with BMN 110 (elosulfase alfa) for Morquio A syndrome (mucopolysaccharidosis IVA): a phase 3 randomised placebo-controlled study.Mortality in patients with morquio syndrome a.Activity of daily living for Morquio A syndrome.International guidelines for the management and treatment of Morquio A syndrome.
P2860
Current and emerging management options for patients with Morquio A syndrome
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Current and emerging management options for patients with Morquio A syndrome
@en
type
label
Current and emerging management options for patients with Morquio A syndrome
@en
prefLabel
Current and emerging management options for patients with Morquio A syndrome
@en
P2860
P356
P1476
Current and emerging management options for patients with Morquio A syndrome
@en
P2093
G Hossein Almassi
Mohamed F Algahim
P2860
P356
10.2147/TCRM.S24771
P577
2013-02-11T00:00:00Z